Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08LAE
|
|||
| Former ID |
DNCL001603
|
|||
| Drug Name |
LGD-4033
|
|||
| Indication | Musculoskeletal disorder [ICD-11: FA00-FC0Z; ICD-10: M00-M99] | Phase 1 | [1] | |
| Company |
Ligand Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H12F6N2O
|
|||
| Canonical SMILES |
C1CC(N(C1)C2=CC(=C(C=C2)C#N)C(F)(F)F)C(C(F)(F)F)O
|
|||
| InChI |
1S/C14H12F6N2O/c15-13(16,17)10-6-9(4-3-8(10)7-21)22-5-1-2-11(22)12(23)14(18,19)20/h3-4,6,11-12,23H,1-2,5H2/t11-,12-/m1/s1
|
|||
| InChIKey |
OPSIVAKKLQRWKC-VXGBXAGGSA-N
|
|||
| CAS Number |
CAS 1165910-22-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030373) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.